• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cutaneous and Mucocutaneous Leishmaniasis Resembling Borderline-tuberculoid Leprosy: A New Clinical Presentation?

Emily

Editor, Senior Moderator
http://www.medicaljournals.se/acta/content/download_preview.php?doi=10.2340/00015555-1338
Cutaneous and Mucocutaneous Leishmaniasis Resembling
Borderline-tuberculoid Leprosy: A New Clinical Presentation?

Federica Dassoni1, Zerihun Abebe2, Bernard Naafs3 and Aldo Morrone1
1National Institute for Health, Migration and Poverty (NIHMP), Rome, Italy, 2Ayder Referral Hospital of Mekele University, Mekele, Ethiopia, and 3Stichting
Tropen Dermatologie, Munnekeburen, The Netherlands

Both cutaneous and mucocutaneous leishmaniasis are
endemic in Northern Ethiopia. The different clinical presentations
depend on the responsible organism and the
host?s immune response. Localized cutaneous leishmaniasis
is the type most frequently seen. Diffuse cutaneous
leishmaniasis is relatively rare and usually associated
with mucous membrane involvement. Diffuse cutaneous
leishmaniasis presents with multiple lesions, can be difficult
to diagnose and responds less favourably to treatment.
We report here 2 patients with unusual presentations
of diffuse cutaneous leishmaniasis presenting with
large hypopigmented skin lesions mimicking borderlinetuberculoid
leprosy. To our knowledge this presentation
has not been described before and may present difficulties
in making a definite diagnosis in regions where both
leprosy and cutaneous leishmaniasis are endemic. Lepromatous
leprosy and diffuse cutaneous leishmaniasis are
regularly confused, particularly when no skin smears
for acid-fast bacillus or Leishman-Donovan bodies are
performed. Key words: leishmaniasis; leprosy; hypopigmentation.
Accepted December 6, 2011.
Acta Derm Venereol 2012; 92: XX?XX

Discussion
Leishmaniasis is one of the top 5 diseases targeted by
the World Health Organization (WHO) Special Program
for Research and Training in Tropical Diseases.
Approximately 1.5 million new cases are documented
each year and more than 350 million people live in
areas of active parasite transmission.
Clinically, localized cutaneous lesions may resemble
other skin conditions; blastomycosis, sporotrichosis,
cutaneous anthrax, eczema, fungal skin infections,
lepromatous leprosy, Mycobacterium marinum infections,
sarcoidosis, basal and squamous cell carcinomas,
tuberculosis and infected insect bites. When the plaque
lesions of CL are located on the face: systemic lupus erythematosus,
discoid lupus erythematosus, sarcoidosis,
lupus vulgaris, cutaneous lymphoma and erysipelas are
in the differential diagnosis....
 
Back
Top Bottom